Comment on "Diverse psychotomimetics act through a common signaling pathway".
Seeman
Philip
P
Departments of Pharmacology, and Psychiatry, 1 King's College Circle, University of Toronto, Toronto, Ontario, Canada M5S 1A8. philip.seeman@utoronto.ca
D000662:Amphetamines / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002491:Central Nervous System Agents / Q000378:metabolism / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D018491:Dopamine Agonists / Q000378:metabolism / Q000494:pharmacology; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D051379:Mice; D018345:Mice, Knockout; D009419:Nerve Tissue Proteins; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism*; D011618:Psychotic Disorders / Q000209:etiology / Q000378:metabolism; D017448:Receptors, Dopamine D2 / Q000819:agonists / Q000378:metabolism*; D015398:Signal Transduction; D009435:Synaptic Transmission
D000662:Amphetamines; D002491:Central Nervous System Agents; D018491:Dopamine Agonists; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D009419:Nerve Tissue Proteins; D010750:Phosphoproteins; D017448:Receptors, Dopamine D2; D004298:Dopamine